Valuation (59%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 7.92 | 7.78 |
| PEG Ratio (TTM) | 0.39 | 0.28 |
| P/S Ratio (TTM) | 2.07 | 2.83 |
| P/B Ratio (TTM) | 1.68 | 1.60 |
| P/FCF Ratio (TTM) | N/A | 39.47 |
| Price to 5YR AVG Earnings Ratio | 0.70 | 16.02 |
| Price to 5YR AVG FCF Ratio | 72.74 | 33.04 |
Profitability (70%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 8.18% | 8.18% |
| ROE (TTM) | 23.65% | 17.40% |
| Net Profit Margin (TTM) | 26.50% | 30.70% |
| ROIC 5YR AVG | 25.41% | 6.63% |
Growth (75%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 51.58% | 174.23% | 133.29% |
| Revenue | 9.86% | 19.75% | 17.92% |
| Net Income | 52.32% | 26.56% | 40.55% |
| Cash Flow | N/A | -119.78% | -38.95% |
Health (39%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.78 | 24.44 |
| Quick Ratio (TTM) | 0.78 | 23.22 |
| D/E Ratio (TTM) | N/A | 0.22 |
| Interest Coverage (TTM) | N/A | 10.69 |
| Piotroski F-Score | 7 | 6 |
| Altman Z-Score | 2.26 | 2.66 |
| LTL to 5YR AVG FCF | 0.04 | 4.46 |
| Shares Outstanding Growth 5YR AVG | 8.95% | -2.53% |